U.S. Airlines Stock News

Crinetics Pharmaceuticals (CRNX) has drawn fresh attention after reporting second quarter 2026 results on 3 August. Revenue reached US$25.12 million, while the company reported a net loss of US$120.86 million for the period. See our latest analysis for Crinetics Pharmaceuticals. The latest results arrived after a period of strong price gains, with Crinetics Pharmaceuticals trading at US$84.70 and showing a 90 day share price return of 130.35%. The 1 year total shareholder return is 175.72%,...

In August 2026, Insulet Corporation reported second-quarter 2026 results showing revenue of US$801.7 million and net income of US$95.0 million, with diluted earnings per share from continuing operations of US$1.37, all higher than the same period a year earlier. For the first half of 2026, Insulet’s revenue of US$1.56 billions and net income of US$186.1 million highlight stronger profitability alongside its new guidance calling for double‑digit GAAP revenue growth for the third quarter and...

Energy price swings linked to Iran have kept inflation expectations and central bank policy in the spotlight, which has made reliable income harder to find. That is why Dividend Powerhouses with 3%+ yields and solid coverage can feel so appealing right now. This article walks through three stocks from the Dividend Powerhouses screener that stand out for income focused investors seeking consistency. The three Dividend Powerhouses highlighted below are just a sample, and the full screen...

Recent activist communications around ASA Gold and Precious Metals (ASA) have focused squarely on governance and oversight. For investors, the debate over board expertise and future management structure now sits at the center of the stock’s story. See our latest analysis for ASA Gold and Precious Metals. Against that backdrop, ASA Gold and Precious Metals has seen a 1-month share price return of 14.74% from a latest close of US$58.60, even though the 3-month share price return declined 9.48%...

T1 Energy Inc. reported past second-quarter 2026 results showing sales and revenue rising to US$250.13 million from US$132.77 million a year earlier, while net loss widened to US$43.54 million but loss per share narrowed, and it also launched a US$75.57 million follow-on common stock offering at US$5.55 per share. Alongside these results, T1 Energy highlighted progress on its G2_Austin domestic solar cell facility and new offtake agreements, reinforcing its effort to build a traceable,...

ACM Research (ACMR) is back in focus after raising its full year 2026 revenue guidance to a range of US$1.125b to US$1.175b, following a strong second quarter earnings report. See our latest analysis for ACM Research. Despite the raised guidance and strong recent earnings, ACM Research’s share price has eased in the short term, with a 1-month share price return down 12.55% and a 7-day share price return down 4.03%. This pullback sits against a much stronger backdrop, including a 90-day share...

Innoviva earnings jolt and share buyback completion Innoviva (INVA) is back in focus after second quarter results showed higher revenue alongside a swing to a net loss, while the company also completed a previously announced share repurchase program. See our latest analysis for Innoviva. At a share price of $21.19, Innoviva’s recent 1-day share price return of 2.12% and 7-day share price return of 3.32% sit against a softer 30-day share price return. The 3-year total shareholder return of...

Woodward stock has delivered a strong 221.4% return over the past 5 years. At around US$370 a share, the question now is whether that run still lines up with what valuation tools suggest, given that the Discounted Cash Flow (DCF) estimate points to a price that is close to fair while earnings-based multiples screen the stock as expensive. A 221.4% gain over 5 years highlights how strongly the Woodward share price has moved, which raises the bar for any new buyers looking for further...

ARS Pharmaceuticals came into this earnings season with a bruised stock and a bullish long-term story. The shares are down about 25% over the past month and dropped another 7.4% to US$5.65 in the first full session after the release. The headline this quarter is not the top line. It is the cost base and the margin squeeze that still sits between neffy’s revenue and any path to profit. Q2 revenue reached US$33.7m, with neffy delivering US$26.2m and a gross margin of about 62%. Yet operating...

In August 2026, Elucent Medical Inc. announced that Knowles Corporation would manufacture its smart surgical guidance device for the EnVisio In-Body Spatial Intelligence System, leveraging Knowles’ precision MedTech capabilities and ISO 13485-certified, FDA-registered facility in Penang, Malaysia. This collaboration underscores Knowles’ role as a MedTech manufacturing partner that helps customers improve product reliability, scalability, and time to market through design optimization and...

Ferrari (NYSE:RACE) is back in focus after its recent share price move, with the stock closing at $414.85 on 13 August 2026. Investors are reassessing the company’s valuation and recent performance metrics. See our latest analysis for Ferrari. For context, Ferrari’s recent 1 month share price return of 10.41% and 3 month share price return of 29.16% point to building momentum, even though the 1 year total shareholder return declined 8.88% and the 5 year total shareholder return sits at...

Howmet Aerospace stock has delivered very strong multi year returns, yet at around US$289 per share the Discounted Cash Flow (DCF) intrinsic value estimate and the market based valuation checks both point to a premium price rather than a clear bargain. Howmet Aerospace has returned about 8x over the past 5 years, which puts extra focus on whether the current price already embeds optimistic expectations. Recent earnings growth and higher expectations for aerospace demand can support a...

United States Antimony Corporation has now reported its past second-quarter 2026 results, with sales of US$7.93 million and net income of US$110,290, down from sales of US$10.53 million and net income of US$181,555 a year earlier. For the first half of 2026, sales fell to US$14.71 million while the company swung from net income of US$728,079 to a net loss of US$11.18 million, highlighting a sharp deterioration in profitability despite earlier growth expectations. We’ll now examine how this...

Recent projections around Analog Devices (ADI) have put the stock in focus, as analysts expect sharp year over year increases in quarterly earnings and revenue tied to industrial and data center demand. See our latest analysis for Analog Devices. At a share price of US$389.39, Analog Devices has seen strong positive momentum this year, with a 42.25% year to date share price return and a 70.37% total shareholder return over the past 12 months. This suggests investors are reassessing both...

Banner stock has delivered a strong 85.0% return over the past three years, and the current Excess Returns intrinsic value estimate still points to the shares trading at a sizeable discount to that assessment. At the same time, traditional market multiples suggest the pricing is about right, which puts extra focus on how investors read the recent move and the new buyback plan. Over the last three years, Banner has returned 85.0%. This places more weight on whether the current price already...

In 2026, Las Vegas Sands reported quarterly results that missed analyst expectations, with earnings per share falling well short and revenue also coming in below consensus, alongside a year-over-year earnings decline. Analyst sentiment has weakened as earnings forecasts were revised downward and the stock received a bearish ranking, highlighting growing concern about the company’s near-term profit trajectory. Next, we’ll explore how these weaker-than-expected earnings and negative revisions...

In early August 2026, CVS Health reported second-quarter sales of US$35,117 million and net income of US$2,979 million, while raising full-year GAAP diluted EPS guidance to US$6.84–US$7.04 and projecting at least US$414.00 billion in revenue and up to US$9.07 billion in net income attributable to CVS Health. At the same time, CVS Health overhauled its weight management offering around GLP-1 therapies, cutting MinuteClinic digital visit prices to US$29 and partnering with Eli Lilly to...

Earlier this week, ManpowerGroup announced that Paychex President and CEO John B. Gibson, Jr. will join its Board of Directors effective September 1, 2026, bringing decades of experience in human capital management, technology, and global HR services. Gibson’s background in scaling digital HR platforms and executing large acquisitions, such as Paychex’s purchase of Paycor, could inform how ManpowerGroup advances its own technology and service offering mix. We’ll now explore how adding...

On 14 August 2026, Starfighters Space, Inc. reported it would miss the SEC deadline for filing its next Form 10-Q, signaling a delay in its quarterly financial disclosure. This filing delay can draw attention because it often points to underlying financial reporting or operational complexities that investors will watch closely. Next, we examine how Starfighters Space’s delayed 10-Q filing could shape its investment narrative and influence perceptions of financial transparency. AI is about...

Aon (NYSE:AON) appointed Darren Van’t Hof as Head of Tax Credit Financing, Transaction Solutions, to lead its tax credit insurance efforts in renewable energy. Van’t Hof is a nationally recognized renewable energy finance and policy leader, with prior roles including interim President and CEO of the Solar Energy Industries Association. He previously led U.S. Bancorp's Impact Finance business, which adds experience in sustainable finance and energy transition to Aon's advisory...

Workday (WDAY) has suddenly moved back into focus after reports that private equity firm Silver Lake is in talks to acquire the cloud software company, with the news sending the stock sharply higher. See our latest analysis for Workday. Beyond the Silver Lake headlines, Workday's share price has swung sharply, with a 40.09% 30 day share price return and 58.93% 90 day share price return. However, a 12.12% decline in 1 year total shareholder return shows longer term holders are still under...

Recent operating gains put Urban Outfitters stock in focus Urban Outfitters (URBN) has drawn fresh investor attention after reporting 4.8% same-store sales growth alongside a 4.6% annual rise in store count over the past two years, highlighting recent operational momentum. See our latest analysis for Urban Outfitters. At a share price of US$77.81, Urban Outfitters has seen a 12.85% 90 day share price return, while its 3 year total shareholder return of 117.71% shows how strongly longer term...

Recently, Europe’s liquid hydrogen market was reported as expanding from about US$7.20 billion in 2026 to a projected US$13.10 billion by 2035, supported by stricter decarbonization mandates and rising infrastructure investment, with Linde holding an estimated share above 22% and enlarging its distribution footprint. This growth trajectory underlines how Linde’s established position in hydrogen and its role in hard-to-abate sectors could enhance its exposure to Europe’s deep decarbonization...

Earlier this month, ImmunityBio, Inc. appointed former World Bank president Dr. Jim Yong Kim as Vice Chairman, creating an Office of the Executive Chairman to concentrate on global strategy, partnerships, and international access to the company’s immunotherapy platform and approved therapies outside the United States. By adding a leader with deep experience in global health and multilateral institutions, ImmunityBio is signaling an intent to deepen its engagement with governments and public...